the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine, namely, immunology, and can be used u0434u043bu00a0 diagnosis active u0442u0435u0447u0435u043du0438u00a0 chronic glomerulonephritis. the purpose of u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 - improving the accuracy of the method. from the blood of patients u0432u044bu0434u0435u043bu00a0u044eu0442 lymphocytes by density gradient u0444u0438u043au043eu043b - u0432u0435u0440u043eu0433u0440u0430u0444u0438u043du0430, u0438u043du043au0443u0431u0438u0440u0443u044eu0442 them in the presence of the t u0430u043au0442u0438u0432u0438u043du0430.after 3 and 6 h of incubation u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 auto - u0440u043eu0437u0435u0442u043au043eu043eu0431u0440u0430u0437u0443u044eu0449u0438u0445 cells (u043du0435u0437u0440u0435u043bu0430u00a0 u043fu043eu043fu0443u043bu00a0u0446u0438u00a0 t lymphocytes) and with an increase in the growth rate of these cells more than 3.5% u0434u0438u0430u0433u043du043e u0441u0442u0438u0440u0443u044eu0442 active during chronic glomerulonephritis. in comparison with the prototype of the proposed method improves the accuracy of 1.4 times.
展开▼